STOCK TITAN

Virgin Galactic Holdings Inc SEC Filings

SPCE NYSE

Welcome to our dedicated page for Virgin Galactic Holdings SEC filings (Ticker: SPCE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Virgin Galactic’s ambition to carry private astronauts above the Kármán line makes every SEC disclosure a window into spacecraft readiness, ticket backlog, and cash runway. If you have ever asked, “Where can I find the Virgin Galactic quarterly earnings report 10-Q filing?” or wondered how to track Virgin Galactic insider trading Form 4 transactions, you’re in the right place.

Stock Titan’s AI digests hundreds of pages so you don’t have to. Our platform delivers Virgin Galactic SEC filings explained simply: instant highlights of R&D spend in the 10-K, side-by-side revenue trends from successive 10-Qs, and plain-English alerts whenever an 8-K material event surfaces—from test-flight anomalies to new ticket sales tiers.

  • 10-K annual report simplified: see flight-test milestones, manufacturing timelines, and liquidity analysis without scrolling through footnotes.
  • Real-time Form 4 insider transactions: monitor when executives buy or sell after major launch announcements.
  • Proxy statement executive compensation: understand how performance awards hinge on commercial flight cadence.
  • 8-K material events explained: AI flags delays, regulatory approvals, or spacecraft updates the moment they hit EDGAR.

Need deeper insight? Use our AI-powered summaries for quick Virgin Galactic earnings report filing analysis, or ask natural questions like “understanding Virgin Galactic SEC documents with AI” and receive authoritative answers in seconds. Whether you’re tracking Virgin Galactic executive stock transactions Form 4 or benchmarking capex across quarters, Stock Titan delivers every filing type—10-K, 10-Q, 8-K, Form 4, S-8, and more—seconds after EDGAR posts them. Clear, timely, and tailored to the only spaceline trading on the NYSE.

Rhea-AI Summary

Venus Concept Inc. (NASDAQ: VERO) has completed a series of related financing amendments designed to ease near-term liquidity pressure and realign its capital structure.

On 30 June 2025 the Company executed an Exchange Agreement with its senior lender Madryn Health Partners. Two existing secured subordinated convertible notes with aggregate principal of $17.0 million were exchanged for (i) new promissory notes totalling $11.1 million and (ii) 325,651 shares of newly issued Series Y Convertible Preferred Stock priced at $19.96 per share. Each preferred share converts into 9.0909 common shares, implying potential issuance of roughly 3.0 million additional common shares once conversion limits are lifted.

The transaction immediately reduces debt principal by about $5.9 million, shifts a portion of lender exposure into equity and carries no registration requirement under Section 3(a)(9). A Third Amended & Restated Registration Rights Agreement obligates the Company to file a shelf registration for the conversion shares within 60 days after all preferred shares convert.

Concurrently, the Company and Madryn executed several consent and amendment agreements: (1) waiver of minimum liquidity covenants on both the Main Street Priority Loan and the new notes through 31 July 2025, (2) permission to apply the 8 July 2025 interest payment to principal, and (3) a sixteenth amendment to the Bridge Loan extending maturity by one month to 31 July 2025.

To support the larger preferred issuance, Venus filed a Certificate of Amendment increasing authorized Series Y shares from 1.2 million to 1.5 million. A shareholder vote will be sought to remove Nasdaq-related conversion limits.

Overall, the package provides short-term covenant relief and modest debt reduction but adds potential equity dilution and highlights ongoing liquidity constraints, with several key maturities now deferred only to late July 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Venus Concept Inc. (NASDAQ: VERO) has completed a series of related financing amendments designed to ease near-term liquidity pressure and realign its capital structure.

On 30 June 2025 the Company executed an Exchange Agreement with its senior lender Madryn Health Partners. Two existing secured subordinated convertible notes with aggregate principal of $17.0 million were exchanged for (i) new promissory notes totalling $11.1 million and (ii) 325,651 shares of newly issued Series Y Convertible Preferred Stock priced at $19.96 per share. Each preferred share converts into 9.0909 common shares, implying potential issuance of roughly 3.0 million additional common shares once conversion limits are lifted.

The transaction immediately reduces debt principal by about $5.9 million, shifts a portion of lender exposure into equity and carries no registration requirement under Section 3(a)(9). A Third Amended & Restated Registration Rights Agreement obligates the Company to file a shelf registration for the conversion shares within 60 days after all preferred shares convert.

Concurrently, the Company and Madryn executed several consent and amendment agreements: (1) waiver of minimum liquidity covenants on both the Main Street Priority Loan and the new notes through 31 July 2025, (2) permission to apply the 8 July 2025 interest payment to principal, and (3) a sixteenth amendment to the Bridge Loan extending maturity by one month to 31 July 2025.

To support the larger preferred issuance, Venus filed a Certificate of Amendment increasing authorized Series Y shares from 1.2 million to 1.5 million. A shareholder vote will be sought to remove Nasdaq-related conversion limits.

Overall, the package provides short-term covenant relief and modest debt reduction but adds potential equity dilution and highlights ongoing liquidity constraints, with several key maturities now deferred only to late July 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Venus Concept Inc. (NASDAQ: VERO) has completed a series of related financing amendments designed to ease near-term liquidity pressure and realign its capital structure.

On 30 June 2025 the Company executed an Exchange Agreement with its senior lender Madryn Health Partners. Two existing secured subordinated convertible notes with aggregate principal of $17.0 million were exchanged for (i) new promissory notes totalling $11.1 million and (ii) 325,651 shares of newly issued Series Y Convertible Preferred Stock priced at $19.96 per share. Each preferred share converts into 9.0909 common shares, implying potential issuance of roughly 3.0 million additional common shares once conversion limits are lifted.

The transaction immediately reduces debt principal by about $5.9 million, shifts a portion of lender exposure into equity and carries no registration requirement under Section 3(a)(9). A Third Amended & Restated Registration Rights Agreement obligates the Company to file a shelf registration for the conversion shares within 60 days after all preferred shares convert.

Concurrently, the Company and Madryn executed several consent and amendment agreements: (1) waiver of minimum liquidity covenants on both the Main Street Priority Loan and the new notes through 31 July 2025, (2) permission to apply the 8 July 2025 interest payment to principal, and (3) a sixteenth amendment to the Bridge Loan extending maturity by one month to 31 July 2025.

To support the larger preferred issuance, Venus filed a Certificate of Amendment increasing authorized Series Y shares from 1.2 million to 1.5 million. A shareholder vote will be sought to remove Nasdaq-related conversion limits.

Overall, the package provides short-term covenant relief and modest debt reduction but adds potential equity dilution and highlights ongoing liquidity constraints, with several key maturities now deferred only to late July 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Virgin Galactic Holdings (SPCE)?

The current stock price of Virgin Galactic Holdings (SPCE) is $3.12 as of July 11, 2025.

What is the market cap of Virgin Galactic Holdings (SPCE)?

The market cap of Virgin Galactic Holdings (SPCE) is approximately 116.8M.

What is the core business of Virgin Galactic Holdings Inc?

Virgin Galactic specializes in commercial human spaceflight and satellite launch services, utilizing advanced aerospace technology to offer unique space experiences.

How does Virgin Galactic generate revenue?

The company generates revenue primarily through ticket sales for commercial spaceflights and fee-based satellite launch services, in addition to leveraging its integrated manufacturing capabilities.

What distinguishes Virgin Galactic from other aerospace companies?

Its vertical integration, focus on reusable space vehicles, and dual services in human spaceflight and efficient satellite launches set Virgin Galactic apart in the competitive aerospace landscape.

What type of experience can customers expect on a Virgin Galactic flight?

Customers can expect a transformative experience that includes out-of-seat weightlessness, panoramic views of Earth, and a meticulously engineered flight journey from lift-off to landing.

What is the significance of the company’s manufacturing arm?

The wholly-owned manufacturing arm ensures high-quality production and seamless integration of advanced aerospace technology, bolstering both the human spaceflight and satellite launch segments.

Where does Virgin Galactic operate its commercial spaceflights?

The company operates its spaceflights from a purpose-built commercial spaceport, which is strategically designed to support comprehensive pre-flight, flight, and post-flight operations.

How does Virgin Galactic support scientific research?

By offering payload capacity for research experiments and providing reliable launch services for small satellites, Virgin Galactic facilitates scientific exploration and advancements in space technology.

What are the key technologies behind Virgin Galactic's operations?

The company employs advanced aerospace innovations such as reusable spaceplane technology, efficient launch systems, and rigorous safety protocols to ensure reliable and transformative spaceflight experiences.
Virgin Galactic Holdings Inc

NYSE:SPCE

SPCE Rankings

SPCE Stock Data

116.83M
39.67M
4.74%
33.02%
30.2%
Aerospace & Defense
Transportation Services
Link
United States
TUSTIN